Last checked at 27 Nov 2014 15:24
27 November 2014
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of veterinary services, announces that on 26 November 2014, certain employees of the Company, exercised options at 2.15 pence per share over an aggregate of 999 ordinary shares of 0.2 pence each in the Company (the "New Shares"), under the CVS Group SAYE scheme.
Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing ordinary shares, to be admitted to trading on AIM which is expected to occur on or about 2 December 2014 ("Admission").
Following Admission, the Company's total issued share capital will consists of 58,904,239 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following Admission, the total number of voting rights in the Company will be 58,904,239. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Contacts:
CVS Group plc Simon Innes, Chief Executive Nick Perrin, Finance Director
| Tel: 01379 644 288
|
N+1 Singer (Nominated Adviser & Broker) Aubrey Powell Alex Wright
| Tel: 020 7496 3000
|